Synopsis
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Chlorhexidine HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine HCl manufacturer or Chlorhexidine HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine HCl manufacturer or Chlorhexidine HCl supplier.
PharmaCompass also assists you with knowing the Chlorhexidine HCl API Price utilized in the formulation of products. Chlorhexidine HCl API Price is not always fixed or binding as the Chlorhexidine HCl Price is obtained through a variety of data sources. The Chlorhexidine HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chlorhexidine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexidine HCl, including repackagers and relabelers. The FDA regulates Chlorhexidine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexidine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexidine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexidine HCl supplier is an individual or a company that provides Chlorhexidine HCl active pharmaceutical ingredient (API) or Chlorhexidine HCl finished formulations upon request. The Chlorhexidine HCl suppliers may include Chlorhexidine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexidine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorhexidine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorhexidine HCl active pharmaceutical ingredient (API) in detail. Different forms of Chlorhexidine HCl DMFs exist exist since differing nations have different regulations, such as Chlorhexidine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorhexidine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorhexidine HCl USDMF includes data on Chlorhexidine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorhexidine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorhexidine HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chlorhexidine HCl Drug Master File in Japan (Chlorhexidine HCl JDMF) empowers Chlorhexidine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chlorhexidine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Chlorhexidine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chlorhexidine HCl suppliers with JDMF on PharmaCompass.
A Chlorhexidine HCl CEP of the European Pharmacopoeia monograph is often referred to as a Chlorhexidine HCl Certificate of Suitability (COS). The purpose of a Chlorhexidine HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Chlorhexidine HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Chlorhexidine HCl to their clients by showing that a Chlorhexidine HCl CEP has been issued for it. The manufacturer submits a Chlorhexidine HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Chlorhexidine HCl CEP holder for the record. Additionally, the data presented in the Chlorhexidine HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Chlorhexidine HCl DMF.
A Chlorhexidine HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Chlorhexidine HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Chlorhexidine HCl suppliers with CEP (COS) on PharmaCompass.
A Chlorhexidine HCl written confirmation (Chlorhexidine HCl WC) is an official document issued by a regulatory agency to a Chlorhexidine HCl manufacturer, verifying that the manufacturing facility of a Chlorhexidine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorhexidine HCl APIs or Chlorhexidine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorhexidine HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorhexidine HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorhexidine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorhexidine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorhexidine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorhexidine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorhexidine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorhexidine HCl suppliers with NDC on PharmaCompass.
Chlorhexidine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorhexidine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorhexidine HCl GMP manufacturer or Chlorhexidine HCl GMP API supplier for your needs.
A Chlorhexidine HCl CoA (Certificate of Analysis) is a formal document that attests to Chlorhexidine HCl's compliance with Chlorhexidine HCl specifications and serves as a tool for batch-level quality control.
Chlorhexidine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Chlorhexidine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorhexidine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorhexidine HCl EP), Chlorhexidine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorhexidine HCl USP).
